Global Atropine API Market Research Report 2024

Publication ID:

PB504240424

Publication Date:

April 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Atropine is racemic hyoscyamine extracted from belladonna, datura and other plants of the same genus in the Solanaceae family. Its chemical formula is C17H23NO3. Its sulfate is a colorless crystal or white powder that is easily soluble in water. Atropine API is mainly used to prepare atropine drugs. Its main pharmacological effects are to block M choline receptors, relieve smooth muscle spasm (including relieving vasospasm and improving microvascular circulation), inhibit gland secretion, and relieve the inhibition of the vagus nerve on the heart. , speed up the heartbeat, dilate pupils, increase intraocular pressure, and excite the respiratory center. In addition, atropine can also excite or inhibit the central nervous system in a dose-dependent manner.
The global Atropine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Atropine API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atropine API include C2 Pharma, Katsura Chemical, HENAN PURUI, SAURAV CHEMICALS, ROLABO OUTSOURCING, Alchem International, Minsheng, RESONANCE LABORATORIES, Anant Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atropine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine API.
The Atropine API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Atropine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
C2 Pharma
Katsura Chemical
HENAN PURUI
SAURAV CHEMICALS
ROLABO OUTSOURCING
Alchem International
Minsheng
RESONANCE LABORATORIES
Anant Labs
Segment by Type
Purity 98%
Purity 99%
Purity 99.9%
Others
Segment by Application
Gastrointestinal Drugs
Urinary System Drugs
Ophthalmic Drugs
Respiratory Medications
Cardiovascular Drugs
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Atropine API Market Overview
1.1 Product Definition
1.2 Atropine API by Type
1.2.1 Global Atropine API Market Value Comparison by Type (2024-2030)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.2.4 Purity 99.9%
1.2.5 Others
1.3 Atropine API by Application
1.3.1 Global Atropine API Market Value by Application (2024-2030)
1.3.2 Gastrointestinal Drugs
1.3.3 Urinary System Drugs
1.3.4 Ophthalmic Drugs
1.3.5 Respiratory Medications
1.3.6 Cardiovascular Drugs
1.3.7 Others
1.4 Global Atropine API Market Size Estimates and Forecasts
1.4.1 Global Atropine API Revenue 2019-2030
1.4.2 Global Atropine API Sales 2019-2030
1.4.3 Global Atropine API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atropine API Market Competition by Manufacturers
2.1 Global Atropine API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atropine API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atropine API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Atropine API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atropine API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atropine API, Product Type & Application
2.7 Global Key Manufacturers of Atropine API, Date of Enter into This Industry
2.8 Global Atropine API Market Competitive Situation and Trends
2.8.1 Global Atropine API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Atropine API Players Market Share by Revenue
2.8.3 Global Atropine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine API Market Scenario by Region
3.1 Global Atropine API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atropine API Sales by Region: 2019-2030
3.2.1 Global Atropine API Sales by Region: 2019-2024
3.2.2 Global Atropine API Sales by Region: 2025-2030
3.3 Global Atropine API Revenue by Region: 2019-2030
3.3.1 Global Atropine API Revenue by Region: 2019-2024
3.3.2 Global Atropine API Revenue by Region: 2025-2030
3.4 North America Atropine API Market Facts & Figures by Country
3.4.1 North America Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atropine API Sales by Country (2019-2030)
3.4.3 North America Atropine API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atropine API Market Facts & Figures by Country
3.5.1 Europe Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atropine API Sales by Country (2019-2030)
3.5.3 Europe Atropine API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine API Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atropine API Sales by Region (2019-2030)
3.6.3 Asia Pacific Atropine API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atropine API Market Facts & Figures by Country
3.7.1 Latin America Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atropine API Sales by Country (2019-2030)
3.7.3 Latin America Atropine API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atropine API Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atropine API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atropine API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atropine API Sales by Type (2019-2030)
4.1.1 Global Atropine API Sales by Type (2019-2024)
4.1.2 Global Atropine API Sales by Type (2025-2030)
4.1.3 Global Atropine API Sales Market Share by Type (2019-2030)
4.2 Global Atropine API Revenue by Type (2019-2030)
4.2.1 Global Atropine API Revenue by Type (2019-2024)
4.2.2 Global Atropine API Revenue by Type (2025-2030)
4.2.3 Global Atropine API Revenue Market Share by Type (2019-2030)
4.3 Global Atropine API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atropine API Sales by Application (2019-2030)
5.1.1 Global Atropine API Sales by Application (2019-2024)
5.1.2 Global Atropine API Sales by Application (2025-2030)
5.1.3 Global Atropine API Sales Market Share by Application (2019-2030)
5.2 Global Atropine API Revenue by Application (2019-2030)
5.2.1 Global Atropine API Revenue by Application (2019-2024)
5.2.2 Global Atropine API Revenue by Application (2025-2030)
5.2.3 Global Atropine API Revenue Market Share by Application (2019-2030)
5.3 Global Atropine API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 C2 Pharma
6.1.1 C2 Pharma Company Information
6.1.2 C2 Pharma Description and Business Overview
6.1.3 C2 Pharma Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 C2 Pharma Atropine API Product Portfolio
6.1.5 C2 Pharma Recent Developments/Updates
6.2 Katsura Chemical
6.2.1 Katsura Chemical Company Information
6.2.2 Katsura Chemical Description and Business Overview
6.2.3 Katsura Chemical Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Katsura Chemical Atropine API Product Portfolio
6.2.5 Katsura Chemical Recent Developments/Updates
6.3 HENAN PURUI
6.3.1 HENAN PURUI Company Information
6.3.2 HENAN PURUI Description and Business Overview
6.3.3 HENAN PURUI Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HENAN PURUI Atropine API Product Portfolio
6.3.5 HENAN PURUI Recent Developments/Updates
6.4 SAURAV CHEMICALS
6.4.1 SAURAV CHEMICALS Company Information
6.4.2 SAURAV CHEMICALS Description and Business Overview
6.4.3 SAURAV CHEMICALS Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SAURAV CHEMICALS Atropine API Product Portfolio
6.4.5 SAURAV CHEMICALS Recent Developments/Updates
6.5 ROLABO OUTSOURCING
6.5.1 ROLABO OUTSOURCING Company Information
6.5.2 ROLABO OUTSOURCING Description and Business Overview
6.5.3 ROLABO OUTSOURCING Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ROLABO OUTSOURCING Atropine API Product Portfolio
6.5.5 ROLABO OUTSOURCING Recent Developments/Updates
6.6 Alchem International
6.6.1 Alchem International Company Information
6.6.2 Alchem International Description and Business Overview
6.6.3 Alchem International Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Alchem International Atropine API Product Portfolio
6.6.5 Alchem International Recent Developments/Updates
6.7 Minsheng
6.7.1 Minsheng Company Information
6.7.2 Minsheng Description and Business Overview
6.7.3 Minsheng Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Minsheng Atropine API Product Portfolio
6.7.5 Minsheng Recent Developments/Updates
6.8 RESONANCE LABORATORIES
6.8.1 RESONANCE LABORATORIES Company Information
6.8.2 RESONANCE LABORATORIES Description and Business Overview
6.8.3 RESONANCE LABORATORIES Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 RESONANCE LABORATORIES Atropine API Product Portfolio
6.8.5 RESONANCE LABORATORIES Recent Developments/Updates
6.9 Anant Labs
6.9.1 Anant Labs Company Information
6.9.2 Anant Labs Description and Business Overview
6.9.3 Anant Labs Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Anant Labs Atropine API Product Portfolio
6.9.5 Anant Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine API Industry Chain Analysis
7.2 Atropine API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine API Production Mode & Process
7.4 Atropine API Sales and Marketing
7.4.1 Atropine API Sales Channels
7.4.2 Atropine API Distributors
7.5 Atropine API Customers
8 Atropine API Market Dynamics
8.1 Atropine API Industry Trends
8.2 Atropine API Market Drivers
8.3 Atropine API Market Challenges
8.4 Atropine API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

C2 Pharma
Katsura Chemical
HENAN PURUI
SAURAV CHEMICALS
ROLABO OUTSOURCING
Alchem International
Minsheng
RESONANCE LABORATORIES
Anant Labs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂